Keyphrases
Albumin Endocytosis
100%
Angiotensin II (Ang II)
100%
AT1 Receptor Antagonists
14%
AT2 Receptor
100%
Basal Activity
14%
Clathrin-mediated
14%
Inhibitor-2
14%
Interstitial Disease
14%
LLC-PK1
14%
LLC-PK1 Cells
14%
Losartan
14%
LY294002
14%
Membrane Fraction
14%
Pathophysiological Conditions
14%
PD123319
28%
PDK1
14%
Phosphatidylinositol 3-kinase Inhibitor
14%
Phosphoinositide 3-kinase (PI3K)
14%
Phosphorylation
14%
Plasma Membrane
14%
Protein Kinase B
100%
Receptor Antagonist
14%
Receptor-mediated
100%
Renal Tubular Epithelial Cells
100%
Selective Phosphorylation
14%
Staurosporine
28%
Wortmannin
14%
Medicine and Dentistry
1 (4 Dimethylamino 3 Methylbenzyl) 5 Diphenylacetyl 4,5,6,7 Tetrahydro 1h imidazo[4,5 C]pyridine 6 Carboxylic Acid
28%
Angiotensin 1 Receptor Antagonist
14%
Angiotensin 2 Receptor Antagonist
14%
Angiotensin II
100%
Cell Membrane
14%
Clathrin
14%
Disease
14%
Endocytosis
100%
Losartan
14%
LY294002
14%
Phosphoinositide 3-Kinase
14%
Phosphoinositide 3-Kinase Inhibitor
14%
Phosphoinositide Dependent Protein Kinase 1
14%
Protein Kinase B
100%
Protein Kinase B Inhibitor
14%
Receptor
100%
Staurosporine
28%
Wortmannin
14%
Neuroscience
Angiotensin II
100%
Cell Membrane
14%
Clathrin
14%
Eicosanoid Receptor
100%
Endocytosis
100%
Losartan
14%
LY294002
14%
Phosphoinositide 3-Kinase
14%
Phosphoinositide 3-Kinase Inhibitor
14%
Phosphoinositide-Dependent Kinase-1
14%
Protein Kinase B
100%
Receptor Antagonist
28%
Staurosporine
28%
Wortmannin
14%
Pharmacology, Toxicology and Pharmaceutical Science
1 (4 Dimethylamino 3 Methylbenzyl) 5 Diphenylacetyl 4,5,6,7 Tetrahydro 1h imidazo[4,5 C]pyridine 6 Carboxylic Acid
33%
2 Morpholino 8 Phenylchromone
16%
Angiotensin 1 Receptor Antagonist
16%
Angiotensin 2 Receptor Antagonist
16%
Angiotensin II
100%
Clathrin
16%
Disease
16%
Losartan
16%
Phosphatidylinositol 3 Kinase
16%
Phosphatidylinositol 3 Kinase Inhibitor
16%
Phosphoinositide Dependent Protein Kinase 1
16%
Protein Kinase B
100%
Protein Kinase B Inhibitor
16%
Receptor
100%
Staurosporine
33%
Wortmannin
16%